ACS Early Rule In Pathway Tool

Clinical calculation support · Verify results before clinical use

Patient assessment inputs

Use the same assay and units for both samples and all thresholds.

5 inputs
Value from the first blood sample.
Enter the measured value and follow the correct sampling interval.
Use the reference limit supplied by your laboratory for this assay.
Use a locally approved, assay-specific threshold for the actual sampling interval.
ECG findings and clinical status take priority over this biomarker screen.

Clinical context

Initial assessment of suspected acute coronary syndrome should integrate clinical history, examination, a 12-lead ECG and cardiac troponin. In suspected ACS, the 2025 ACC/AHA guideline recommends obtaining an ECG promptly and measuring cardiac troponin as soon as possible, preferably with a high-sensitivity assay. When the initial result is nondiagnostic, repeat hs-cTn is generally obtained 1 to 2 hours after the initial sample, using a validated clinical decision pathway.

A troponin concentration above the assay-specific 99th-percentile upper reference limit indicates myocardial injury, not automatically myocardial infarction. Acute MI requires a rise and/or fall in cardiac troponin with at least one value above the 99th percentile plus clinical evidence of acute myocardial ischemia.

Validated 0/1-hour and 0/2-hour pathways use assay-specific baseline concentrations and absolute changes. The simplified threshold comparison on this page is not a substitute for those validated pathways and does not independently classify patients as rule-out, observe, or rule-in.

Practical interpretation

  • If the ECG suggests STEMI, follow the urgent ECG-led pathway; do not wait for troponin before indicated reperfusion.
  • Interpret troponin changes with the assay, units, timing of symptom onset and blood collection, symptoms, ECG, hemodynamic status and alternative causes of myocardial injury.
  • If suspicion persists or results are indeterminate, continue serial assessment and use the locally adopted evidence-based clinical decision pathway.

Limitations and safety

  • Thresholds are assay-specific and time-dependent. Confirm units and local laboratory cutoffs before use.
  • A single 99th-percentile URL plus a user-entered delta is not equivalent to a validated hs-cTn algorithm.
  • Elevated hs-cTn may reflect acute or chronic myocardial injury from ischemic and non-ischemic causes.
  • A result below the 99th percentile does not by itself exclude early MI, especially with early symptom onset or ongoing symptoms.
  • Use clinician judgment and local protocols for admission, observation, imaging, cardiology review and reperfusion decisions.

References

Rao SV, et al. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes. Journal of the American College of Cardiology. 2025. doi:10.1016/j.jacc.2024.11.009
Thygesen K, et al. Fourth Universal Definition of Myocardial Infarction (2018). Journal of the American College of Cardiology. 2018;72(18):2231–2264. doi:10.1016/j.jacc.2018.08.1038
Byrne RA, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. European Heart Journal. 2023. doi:10.1093/eurheartj/ehad191